Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-25-051106
Filing Date
2025-03-10
Accepted
2025-03-10 17:23:38
Documents
14

Document Format Files

Seq Description Document Type Size
1 424B5 d847224d424b5.htm 424B5 468596
2 EX-FILING FEES d847224dexfilingfees.htm   iXBRL EX-FILING FEES 50360
3 GRAPHIC g847224g65p50.jpg GRAPHIC 38358
  Complete submission text file 0001193125-25-051106.txt   714608

Data Files

Seq Description Document Type Size
17 EXTRACTED XBRL INSTANCE DOCUMENT d847224dexfilingfees_htm.xml XML 11515
Mailing Address 26 LANDSDOWNE STREET CAMBRIDGE MA 02139
Business Address 26 LANDSDOWNE STREET CAMBRIDGE MA 02139 857-327-8775
Beam Therapeutics Inc. (Filer) CIK: 0001745999 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-277427 | Film No.: 25724941
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)